Fine-tuning of mast cell activation by FcεRIβ chain

Mast cells play a key role in allergic reaction and disorders through the high affinity receptor for IgE (Fc(epsilon)RI) which is primarily activated by IgE and antigen complex. In humans, mast cells express two types of Fc(epsilon)RI on the cell surface, tetrameric alpha beta gamma(2) and trimeric alpha gamma(2), whereas in mice, the tetrameric alpha beta gamma 2 type is exclusively expressed. In human allergic inflammation lesions, mast cells increase in number and preferentially express the alpha beta gamma(2) type Fc(epsilon)RI, By contrast, in the lesion of non-allergic inflammation, mast cells mainly express the alpha gamma(2) type. Since the beta chain amplifies the expression and signaling of Fc epsilon RI, mast cell effector functions and allergic reaction in vivo are enhanced in the presence of the beta chain. In contrast, a truncated beta chain-isoform (beta T) inhibits Fc(Epsilon)RI surface expression. The human Fc(epsilon)RI beta gene contains seven exons and a repressor element located in the forth intron, through which Fc(epsilon)RI transcription is repressed in the presence of GM-CSF. Regarding the additional signal regulatory function of the beta chain, the beta chain ITAM has dual (positive and negative) functions in the regulation of the mast cell activation. Namely, the Fc(epsilon)RI beta chain ITAM enhances the mast cell activation signal triggered by a low-intensity (weak) stimulation whereas it suppresses the signal triggered by high-intensity (strong) stimulation. In an oxazolone-induced mouse CHS model, IgE-mediated mast cell activation is required and the beta chain ITAM is crucially involved. Adenosine receptor, one of the GPCRs, triggers a synergistic degranulation response with Fc epsilon RI in mast cells, for which the beta chain ITAM critically plays positive role, possibly reflecting the in vivo allergic response. These regulatory functions of the Fc epsilon RI ITAM finely tune Fc epsilon RI-induced mast cell activation depending on the stimulation strength, enabling the Fc(epsilon)RI beta chain to become a potential molecular target for the development of new strategies for therapeutic interventions for allergies.